TEL AVIV, Israel, Nov. 26, 2025 /PRNewswire/ -Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused ...
30m
Collplant Biotechnologies Reports 2025 Third Quarter Financial Results And Provides Corporate Update
Expansion of rhCollagen and BioInk raw material sales in North American territories expected through a new partnership with a U.S.-based logistics center scheduled to become operational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback